- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Rubicon Research Ltd (RUBI)
Rubicon Research Ltd stock price live, this page displays NSE RUBI stock exchange data. View the RUBI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Rubicon Research Ltd real time stock price chart below.
What Is the Rubicon Research Ltd Stock Price Today?
The Rubicon Research Ltd stock price today is 1,775.70.
What Is the Stock Symbol for Rubicon Research Ltd?
The stock symbol for Rubicon Research Ltd is "RUBI."
What Stock Exchange Does Rubicon Research Ltd Trade On?
Rubicon Research Ltd is listed and trades on the NSE stock exchange.
Is Rubicon Research Ltd a Good Stock to Buy?
Determining whether Rubicon Research Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RUBI quote. (ISIN: INE506V01022)
What Is the Rubicon Research Ltd Stock Price Today?
The Rubicon Research Ltd stock price today is 1,775.70.
What Is the Stock Symbol for Rubicon Research Ltd?
The stock symbol for Rubicon Research Ltd is "RUBI."
What Stock Exchange Does Rubicon Research Ltd Trade On?
Rubicon Research Ltd is listed and trades on the NSE stock exchange.
Is Rubicon Research Ltd a Good Stock to Buy?
Determining whether Rubicon Research Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RUBI quote. (ISIN: INE506V01022)
1,775.70
-53.10(-2.90%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,765.00
1,839.70
52 wk Range
485.00
1,899.00
RUBI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,765.001,839.70
52 wk Range
485.001,899.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.08%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.08%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
RUBI Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
1,897.50
Upside
+6.86%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 1,897.50
(+6.86% Upside)
Rubicon Research Ltd Earnings Call Summary for Q1/2027
- Rubicon Research Q1 FY27 revenue surged 52% YoY to INR 5,343M; profit after tax nearly doubled to INR 848M with EPS at INR 5.08.
- Gross margin expanded to 67.7%, operating EBITDA rose 63.2% to INR 1,291M with margin at 24.2% despite input cost pressures.
- Management raised full-year FY27 EBITDA margin guidance to 23% from prior 22-23% range, citing improved operating leverage.
- Arinna Lifesciences acquisition added INR 12 crores revenue; new U.S. and Pithampur facilities expected to begin commercialization in 2027.
- Stock traded flat at $1,619.1, near 52-week high; 97% U.S. export exposure and tight liquidity ratio of 0.7 pose key risks.
Last Updated: 2026-08-14, 09:58 a/m
Read Full TranscriptEarnings
Latest Release
Sep 02, 2026
EPS / Forecast
5.08 / 2.60
Revenue / Forecast
5.34B / --
Compare RUBI to Peers and Sector
Metrics to compare | RUBI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRUBIPeersSector | |
|---|---|---|---|---|
P/E Ratio | 105.0x | 25.5x | −0.4x | |
PEG Ratio | 1.33 | 0.10 | 0.00 | |
Price/Book | 23.5x | 2.8x | 2.6x | |
Price / LTM Sales | 15.6x | 3.5x | 3.1x | |
Upside (Analyst Target) | 3.8% | 7.6% | 49.0% | |
Fair Value Upside | Unlock | −1.8% | 7.1% | Unlock |
Rubicon Research Limited operates as a specialty pharmaceutical company in India, the United States, and internationally. The company develops products in the areas of analgesics/pain management, cardiovascular system, central nervous system, hypokalemia, skeletal muscle relaxants, nicotine replacement therapy, gastrointestinal, metabolic, and immunosuppressant. Its primary proprietary technologies for drug delivery comprising RubiReten, a gastro-retentive system for drugs with poor solubility and a limited window of absorption, as well as RubiSRL for the formulation of sustained release liquids using a combination of ion exchange and membrane diffusion controlled-release technologies. The company was incorporated in 1999 and is headquartered in Mumbai, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Rubicon Research (RUBI) Stock Price Today?
The Rubicon Research stock price today is 1,775.70 INR.
What Stock Exchange Does Rubicon Research Trade On?
Rubicon Research is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Rubicon Research?
The stock symbol for Rubicon Research is "RUBI."
Does Rubicon Research Pay Dividends? What’s The Current Dividend Yield?
The Rubicon Research dividend yield is 0.08%.
What Is the Rubicon Research Market Cap?
As of today, Rubicon Research market cap is 302.72B INR.
When Is the Next Rubicon Research Earnings Date?
Rubicon Research will release its next earnings report on Dec 02, 2026.
From a Technical Analysis Perspective, Is RUBI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Rubicon Research Stock Split?
Rubicon Research has split 0 times.
How Many Employees Does Rubicon Research Have?
Rubicon Research has 1290 employees.
What is the current trading status of Rubicon Research (RUBI)?
As of Sep 03, 2026, Rubicon Research (RUBI) is trading at a price of 1,775.70 INR, with a previous close of 1,828.80 INR. The stock has fluctuated within a day range of 1,765.00 INR to 1,839.70 INR, while its 52-week range spans from 485.00 INR to 1,899.00 INR.
What Is Rubicon Research (RUBI) Price Target According to Analysts?
The average 12-month price target for Rubicon Research is 1,897.50 INR, with a high estimate of 1915 INR and a low estimate of 1880 INR. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +6.86% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.